NextGen InigoLabs LLC — Form D
NextGen InigoLabs LLC of BALTIMORE, MD, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2022-04-29. $65K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-04-29
- Form: D
- Accession: 0001567619-22-009159
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.1
- Amount sold: $65K
- Investors: 4
- Date of first sale: 2022-04-19
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-443864
Issuer
- Name: NextGen InigoLabs LLC
- CIK: 0001926212
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 901 S BOND STREET, SUITE 400, BALTIMORE, MD, 21231
- Phone: 410-537-5400
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| n/a NextGen Venture Partners, LLC | Executive Officer | Baltimore, MD |
| David M Churchill | Director | BALTIMORE, MD |
| David M Churchill | Executive Officer | BALTIMORE, MD |
| Brett D Rogers | Director | BALTIMORE, MD |
| Brett D Rogers | Executive Officer | BALTIMORE, MD |
| Michael D Hankin | Director | Baltimore, MD |
| Michael D Hankin | Executive Officer | Baltimore, MD |
| Daniel D Mindus | Executive Officer | Baltimore, MD |
Other filings by this issuer (2)
More